Ontology highlight
ABSTRACT: Objectives
To assess real-world treatment patterns and healthcare resource utilization (HRU) among patients with FLT3-mutated (FLT3mut ) and FLT3-wild-type (FLT3wt ) acute myeloid leukemia (AML).Methods
Data were abstracted from medical charts of patients with AML from 10 countries. Patients were grouped based on their FLT3 mutation status, age (18-64 or ≥65), and whether they were newly diagnosed (ND) or relapsed/refractory (R/R).Results
Charts of 1027 AML patients were included (183 FLT3mut 18-64 ND; 136 FLT3mut ≥65 ND; 181 FLT3mut R/R; 186 FLT3wt 18-64 ND; 159 FLT3wt ≥65 ND; 182 FLT3wt R/R). Substantial heterogeneity was observed in treatment patterns for AML. Among ND patient
SUBMITTER: Griffin JD
PROVIDER: S-EPMC6850763 | biostudies-literature | 2019 Apr
REPOSITORIES: biostudies-literature